Representative Julia Letlow (R-Louisiana) recently sold shares of State Street Corporation (NYSE: STT). In a filing disclosed on January 13th, the Representative disclosed that they had sold between $
Representative Julia Letlow (R-Louisiana) recently bought shares of Waters Corporation (NYSE: WAT). In a filing disclosed on January 13th, the Representative disclosed that they had bought between $1,
Representative Julia Letlow (R-Louisiana) recently bought shares of The Walt Disney Company (NYSE: DIS). In a filing disclosed on January 13th, the Representative disclosed that they had bought betwee
Representative Julia Letlow (R-Louisiana) recently sold shares of Pinterest, Inc. (NYSE: PINS). In a filing disclosed on January 13th, the Representative disclosed that they had sold between $1,001 an
Representative Julia Letlow (R-Louisiana) recently sold shares of Warner Bros. Discovery, Inc. (NASDAQ: WBD). In a filing disclosed on January 13th, the Representative disclosed that they had sold bet
Representative Julia Letlow (R-Louisiana) recently bought shares of Devon Energy Corporation (NYSE: DVN). In a filing disclosed on January 13th, the Representative disclosed that they had bought betwe
Astrazeneca (AZN) closed the most recent trading day at $96.34, moving +1.94% from the previous trading session.
AstraZeneca PLC (AZN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
BOSTON--(BUSINESS WIRE)-- #AstraZeneca--Modella AI Announces Acquisition by AstraZeneca to Advance AI-Driven Oncology R&D at Global Scale.
Tempus AI (TEM) shares rose about 10% on Monday after the company filed preliminary, unaudited results showing roughly $1.27 billion in 2025 revenue.The filing
Tempus AI (NASDAQ: TEM) stock rose after releasing preliminary Q4 and 2025 results, with revenue of $1.27B in 2025 and $367M in Q4.
AstraZeneca started 2026 on a high note. On January 7, its stock reached an all-time high of $95.94. The key drivers of increased investor interest in AstraZeneca are the strong performance of its onc
If a recession were to hit, it's a foregone conclusion that people won't stop taking their prescriptions, and they won't cancel major medical treatments.
D.A. Davidson and CO. lessened its stake in shares of AstraZeneca PLC (NASDAQ: AZN) by 18.0% in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The institut
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE